Analgesics in the Netherlands
1. INTRODUCTION
2. EXECUTIVE SUMMARY
3. OPERATING ENVIRONMENT
3.1 Registration and Classification
3.2 Advertising
3.3 Packaging and Labelling
3.4 Distribution
3.5 De-listing or de-reimbursement
3.6 Traditional Remedies
3.7 Homeopathy
3.8 Generics
3.9 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 1998-2002
3.10 Life Expectancy
Table 2 Life Expectancy at Birth 1998-2002
4. OTC HEALTHCARE
4.1 Market Performance
Table 3 Retail Sales of OTC Healthcare by Sector: Value 1998-2003
Table 4 Retail Sales of OTC Healthcare by Sector: % Value Growth 1998-2003
4.2 Switches
Summary 1 OTC Healthcare Switches 2002-2003
4.3 Competitive Environment
4.4 Roche Nederland BV
Summary 2 Roche Operational Indicators 2003
4.5 Boehringer Ingelheim
Summary 3 Boehringer Ingelheim Operational Indicators 2003
4.6 Chefaro
Summary 4 Chefaro Operational Indicators 2003
4.7 Bional Pharma BV
Summary 5 Bional Pharma BV Operational Indicators 2003
4.8 Retail Distribution
Table 5 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 1998/2003
Table 6 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2003
4.9 Retailer Activity and Private Label Trends
4.10 Forecast Market Performance
Table 7 Forecast Retail Sales of OTC Healthcare by Sector: Value 2003-2008
Table 8 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
5. ANALGESICS
5.1 Sector Performance
Table 9 Retail Sales of Analgesics by Subsector: Value 1998-2003
Table 10 Retail Sales of Analgesics by Subsector: % Value Growth 1998-2003
Table 11 Analgesics Company Shares 2001-2003
Table 12 Analgesics Brand Shares 2001-2003
Summary 6 Analgesics: New Product Launches 2002-2003
Table 13 Retail Sales of Analgesics by Standard/Herbal Split 1998/2003
5.2 Forecast Sector Performance
Table 14 Forecast Retail Sales of Analgesics by Subsector: Value 2003-2008
Table 15 Forecast Retail Sales of Analgesics by Subsector: % Value Growth 2003-2008
